Close Menu

With rapid changes to sequencing technology, Dan Koboldt at MassGenomics says that "genomes abound" and that "everyone wants to sequence," though not every lab can afford its own sequencer. Enter sequence service providers such as BGI and Complete Genomics. "These new sequencers and service providers are going to put high-throughput sequencing into the hands of many investigators. Investigators, I might add, who likely have never dealt with NGS data," Koboldt writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.